Back to search
Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit der Wirkstoffkombination aus Tafluprost und Timolol (ATC-Code: S01ED70).
AOK Niedersachsen. Die Gesundheitskasse.GermanyPublished on Feb 12, 2026
464 days left
GermanyDescription
Conclusion of a non-exclusive discount contract under § 130a para. 8 SGB V for medicinal products with the active substance combination of Tafluprost and Timolol (ATC Code: S01ED70) within the period from 01.04.2026 to 31.03.2028 with the possibility of concluding the contract at any time during the term of the contract (open-house model).
CPV codes
Pharmaceutical products
AI summary
Sign in for an AI summaryContains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.
Related tenders
Germany – Medical equipments, pharmaceuticals and personal care products – 1/DLII6/VM109 - RV Impfstoff Influenza
Bundesamt für Infrastruktur, Umweltschutz und Dienstleistungen der BundeswehrGermanyMedical equipments, pharmaceuticals and personal care productsPharmaceutical productsGeneral anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agentsDeadline in 14 daysPublished on Oct 18, 2026
Germany – Medical equipments, pharmaceuticals and personal care products – Blutentnahme
EK-UNICO GmbHGermanyMedical equipments, pharmaceuticals and personal care productsVenepuncture, blood sampling devicesDeadline in 29 daysPublished on Oct 18, 2026
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Pankreatin (ATC-Code nach WHO: A09AA02)
AOK PLUS - Die Gesundheitskasse für Sachsen und ThüringenGermanyPharmaceutical productsDeadline in 42 daysPublished on Oct 18, 2026
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Golimumab (ATC-Code nach WHO: L04AB06)
AOK PLUS - Die Gesundheitskasse für Sachsen und ThüringenGermanyPharmaceutical productsDeadline in 620 daysPublished on Oct 18, 2026